Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine in Patients With Metastatic MelanomaPaul B. Chapman, John M. Kirkwood, Colin B. Begg et al.|Journal of Clinical Oncology|1999Cited by 763
Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome results of a randomised phase 3 trialEthan Basch, Charles S. Cleeland, Karen A. Autio et al.|The Lancet Oncology|2013Cited by 153
Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for childrenAndrew D.J. Pearson, Gilles Vassal, Kimberly Stegmaier et al.|European Journal of Cancer|2020Cited by 25